Vectus Biosystems Limited (ASX:VBS)
Australia flag Australia · Delayed Price · Currency is AUD
0.1400
0.00 (0.00%)
Jan 30, 2026, 10:03 AM AEST

Vectus Biosystems Revenue

In the fiscal year ending June 30, 2025, Vectus Biosystems had annual revenue of 478.18K AUD, down -58.01%. Vectus Biosystems had revenue of 84.48K in the half year ending June 30, 2025, a decrease of -89.10%.

Revenue
478.18K
Revenue Growth
-58.01%
P/S Ratio
15.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.48M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2025478.18K-660.49K-58.01%
Jun 30, 20241.14M-215.86K-15.94%
Jun 30, 20231.35M54.45K4.19%
Jun 30, 20221.30M282.09K27.71%
Jun 30, 20211.02M966.81K1,888.82%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chimeric Therapeutics12.68M
Immuron7.29M
Biotron1.81M
Acrux1.19M
Anatara Lifesciences969.46K
InhaleRx833.90K
Patrys828.54K
AdAlta677.01K
Revenue Rankings